文献
J-GLOBAL ID:201202263817413011
整理番号:12A1666123
代謝疾患:免疫調節性多糖LNFPIIIは代謝経路の直接的,間接的制御を介して脂肪肝とインスリン抵抗性を軽減する
Immunomodulatory glycan LNFPIII alleviates hepatosteatosis and insulin resistance through direct and indirect control of metabolic pathways
著者 (11件):
BHARGAVA Prerna
(Harvard School of Public Health, Massachusetts, USA)
,
STANYA Kristopher J
(Harvard School of Public Health, Massachusetts, USA)
,
JACOBI David
(Harvard School of Public Health, Massachusetts, USA)
,
DAI Lingling
(Harvard School of Public Health, Massachusetts, USA)
,
LIU Sihao
(Harvard School of Public Health, Massachusetts, USA)
,
GANGL Matthew R
(Harvard School of Public Health, Massachusetts, USA)
,
LEE Chih-Hao
(Harvard School of Public Health, Massachusetts, USA)
,
LI Changlin
(Univ. Georgia, Georgia, USA)
,
HARN Donald A
(Univ. Georgia, Georgia, USA)
,
JACOBI David
(Univ. Francois Rabelais, Tours, FRA)
,
DAI Lingling
(Central South Univ., Hunan, CHN)
資料名:
Nature Medicine
(Nature Medicine)
巻:
18
号:
11
ページ:
1665-1672
発行年:
2012年11月
JST資料番号:
W0636A
ISSN:
1078-8956
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)